Acute promyelocytic leukemia treated with idarubicin complicated by focal segmental glomerulosclerosis

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 2, 2010, Pages e82-e84

  Bariş, Safa ^a   Özdil, Mine ^a   Topal, Nilüfer ^a   Doğru, Ömer ^a   Özdemir, Nihal ^a   Sever, Lale ^b   Albayram, Sait ^a   Kiliçaslan, Işin ^c   Celkan, Tiraje ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Acute promyelocytic leukemia; Childhood; Focal segmental glomerulosclerosis; Ischemic stroke; Nephrotic syndrome

Indexed keywords

AMPHOTERICIN B; ANTHRACYCLINE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; IDARUBICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; RETINOIC ACID;

ACUTE LEUKEMIA; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHILD; CLINICAL FEATURE; FEBRILE NEUTROPENIA; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HUMAN; KIDNEY BIOPSY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SCHOOL CHILD;

ANTIBIOTICS, ANTINEOPLASTIC; CHILD; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IDARUBICIN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; NEPHROTIC SYNDROME; THROMBOSIS;

EID: 77949437648     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181b8473a     Document Type: Article

References (22)

1. Loi S, Perry GJ, Standish H, et al. Glomerulosclerosis: a paraneoplastic syndrome. Nephrology. 2004;9: 387-391.
2. Rosado MF, Morgensztern D, Abdullah S, et al. Chronic lymphocytic leukemia-associated nephrotic syndrome caused by focal segmental glomerulosclerosis. Am J Hematol. 2004;77: 205-206.
3. Mallouk A, Pham PT, Pham PC. Concurrent FSGS and Hodgkin’s lymphoma: case report and literature review on the link between nephritic glomerulopathies and hematological malignancies. Clin Exp Nephrol. 2006;10: 284-289.
4. Sanz MA, Jarque I, Martin G. Acute promyelocytic leukemia therapy: results and prognostic factors. Cancer. 1988;1: 7-13.
5. Falanga A, Barbui T. Coagulopathy of acute promyelocytic leukemia. Acta Haematol. 2001;106: 43-51.
6. Levi I, Dinour D, Ben-Bassat B, et al. Acute myeloid leukemia associated with nephrotic syndrome: case report and literature review. Leuk Lymphoma. 2002;43: 1133-1136.
7. Morino N, Nojima Y, Mimura T, et al. Nephrotic syndrome developed in a patient with acute promyelocytic leukemia treated with daunomycin. Nephron. 1995;70: 374-375.
8. Bhatia M, Kher K, Minniti CP. Acute lymphoblastic leukemia in child with nephrotic syndrome. Pediatr Nephrol. 2004;19: 1290-1293.
9. Dosa S, Phillips TM, Antonovych TT, et al. Acute myelomonocytic leukemia associated with nephrotic syndrome. A case report with immunological studies. Nephron. 1983;34: 125-129.
10. Thomson M, de Arriba G, Ordi J, et al. Acute myelogenous leukemia treated with daunomycin associated with nephrotic syndrome. Nephron. 1989;51: 261-264.
11. Omura K, Kawamura T, Utsunomiya Y, et al. Development of nephrotic syndrome in a patient with acute myeloblastic leukemia after treatment with macrophage-colony-stimulating factor. Am J Kidney Dis. 1996;27: 883-887.
12. Sathiapalan RK, Velez MC, McWhorter ME, et al. Focal segmental glomerulosclerosis in children with acute lymphocytic leukemia: case reports and review of literature. J Pediatr Hematol Oncol. 1998;20: 482-485.
13. Bertani T, Cutillo F, Zoja C, et al. Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int. 1986;30: 488-496.
14. Guo J, Ananthakrishnan R, Qu W, et al. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis. J Am Soc Nephrol. 2008;19: 961-972.
15. Escudier SM, Kantarjian HM, Estey EH. Thrombosis in patients with acute promyelocytic leukemia treated with and without all trans retinoic acid. Leuk Lymphoma. 1996;20: 435-439.
16. De Stefano V, Sora F, Rossi E, et al. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost. 2005;3: 1985-1992.
17. Kalk E, Goede A, Rose P. Acute arterial thrombosis in acute promyelocytic leukemia. Clin Lab Hematol. 2003;25: 267-270.
18. Tallman MS, Lefebvre P, Baine RM, et al. Effects of alltrans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukaemia. J Thromb Haemost. 2004;2: 1341-1350.
19. Langer F, Eifreg B, Marx G, et al. Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases. Ann Hematol. 2002;81: 727-731.
20. Murray JC, Dorfman SR, Brandt ML, et al. Renal venous thrombosis complicating acute myeloid leukemia with hyperleukocytosis. J Pediatr Hematol Oncol. 1996;18: 327-330.
21. Runde V, Aul C, Heyll A, et al. All-trans retinoic acid: not only a differentiating agent but also an inducer of thromboembolic events in patients with M3 leukemia. Blood. 1992;79: 534-535.
22. Kardos M, Grexa E, Kajtar P, et al. Incidence of internal carotid artery thrombosis and disseminated intravascular coagulopathy in the early stages of acute myeloid leukemia. Orv Hetil. 1992;133: 483-485.